Literature DB >> 16629121

F-ara-AMP is a substrate of cytoplasmic 5'-nucleotidase II (cN-II): HPLC and NMR studies of enzymatic dephosphorylation.

Lars P Jordheim1, Emeline Cros, Carlos M Galmarini, Charles Dumontet, Anne-Sophie Bretonnet, Isabelle Krimm, Jean-Marc Lancelin, Marie-Claude Gagnieu.   

Abstract

Intracellular accumulation of triphosphorylated derivatives is essential for the cytotoxic activity of nucleoside analogues. Different mechanisms opposing this accumulation have been described. We have investigated the dephosphorylation of monophosphorylated fludarabine (F-ara-AMP) by the purified cytoplasmic 5'-nucleotidase cN-II using HPLC and NMR. These studies clearly showed that cN-II was able to convert F-ara-AMP into its non phosphorylated form, F-ara-A, with a Km in the millimolar range and Vmax = 35 nmol/min/mg, with both methods. Cytoplasmic 5'-nucleotidase cN-II can degrade this clinically useful cytotoxic nucleoside analogue and its overexpression is thus likely to be involved in resistance to this compound.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16629121     DOI: 10.1080/15257770500458027

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  3 in total

1.  Base-modified thymidines capable of terminating DNA synthesis are novel bioactive compounds with activity in cancer cells.

Authors:  Kayla M Borland; Safnas F AbdulSalam; Morwena J Solivio; Matthew P Burke; Patrick R Wolfkiel; Sean M Lawson; Courtney A Stockman; Joel M Andersen; Skyler Smith; Julia N Tolstolutskaya; Purujit N Gurjar; Aron P Bercz; Edward J Merino; Vladislav A Litosh
Journal:  Bioorg Med Chem       Date:  2015-02-14       Impact factor: 3.641

2.  Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues.

Authors:  Franck Gallier; Perrine Lallemand; Maïa Meurillon; Lars P Jordheim; Charles Dumontet; Christian Périgaud; Corinne Lionne; Suzanne Peyrottes; Laurent Chaloin
Journal:  PLoS Comput Biol       Date:  2011-12-08       Impact factor: 4.475

3.  Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation.

Authors:  E Mohanan; J C Panetta; K M Lakshmi; E S Edison; A Korula; N A Fouzia; A Abraham; A Viswabandya; V Mathews; B George; A Srivastava; P Balasubramanian
Journal:  Bone Marrow Transplant       Date:  2017-05-08       Impact factor: 5.483

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.